09:37 JIWA BIO-PHARM<02327> - Announcement (2) at the date of this announcement, the registered capital of the PRC JV Company is as follows: Capital Percentage (RMB) (%) Party A 4,500,000 66.18 Party B 500,000 7.35 Party C 1,800,000 26.47 (see Note 1) Total 6,800,000 100 (see Note 2) Notes: 1. The actual capital contributed by Party C is RMB827,700. 2. The total actual capital contributed by Party A, Party B and Party C is RMB5,827,700 as Party C has not completed its total capital contribution of RMB1,800,000 and the outstanding amount is RMB972,300. The registered capital of the PRC JV Company upon completion of the capital contributions pursuant to the Capital Injection Agreement will be as follows: Capital Percentage (RMB) (%) Jiwa Rintech 24,000,000 80 Party A 4,672,300 15.57 Party B 500,000 1.67 Party C 827,700 2.76 Total 30,000,000 100 Payment Terms: Party A and Jiwa Rintech will make the capital contributions in the PRC JV Company by cash respectively within 3 months from the date of issue of the new business licence of the PRC JV Company. Jiwa Rintech will finance its capital contribution through internal resources. Conditions: The transactions contemplated under the Capital Injection Agreement are conditional, inter alia, on the followings: 1. all necessary approvals from the Ministry of Commerce of the People's Republic of China (*) and the State Administration for Industry and Commerce (*) have been obtained; 2. the signing of the joint venture agreement and the articles of association of the PRC JV Company by Party A, Party B, Party C and Jiwa Rintech; and 3. all necessary actions have been done by Party A, Party B, Party C and Jiwa Rintech in relation to, inter alia, approving the execution and performance of the Capital Injection Agreement and the increase of the registered capital of the PRC JV Company. Others: The board of directors of the PRC JV Company will comprise five directors, four of whom will be nominated by Jiwa